首页> 美国卫生研究院文献>International Journal of Nanomedicine >Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses
【2h】

Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses

机译:阳离子聚合物修饰的PLGA纳米颗粒包裹Alhagi蜂蜜多糖作为卵清蛋白的疫苗递送系统以改善免疫反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Poly (lactic-co-glycolic acid) (PLGA) nanoparticles and surface modified PLGA nanoparticles have been widely studied as antigens or drugs carriers due to their controlled release characteristics and biocompatibility. However, most PLGA nanoparticles have lower antigens loading efficiency and adjuvanticity.>Purpose: The aim of this study was to improve the antigen loading efficiency and adjuvant activity of PLGA nanoparticles.>Materials and methods: Surface cationic polymer modification can improve the antigens loading efficiency of PLGA nanoparticles by surface adsorption. Therefore, in this study, chitosan modified PLGA nanoparticles (CS-AHPP/OVA), polyethyleneimine modified PLGA nanoparticles (PEI-AHPP/OVA), and ε-Poly-L-lysine modified PLGA nanoparticles (εPL-AHPP/OVA) were prepared as antigen delivery carriers to investigate the characterization and stability of these nanoparticles. These nanoparticles were evaluated for their efficacies as adjuvants pre- and post-modification.>Results: The AHP and OVA-loaded PLGA nanoparticles (AHPP/OVA) were positively charged after surface cationic polymers modification, and their structural integrity was maintained. Their antigen loading capacity and stability of nanoparticles were improved by the surface cationic polymers modification. Increased positive surface charge resulted in greater OVA adsorption capacity. Among AHPP/OVA and the three surface cationic polymers synthesized from modified PLGA nanoparticles, PEI-AHPP/OVA showed the highest antigen loading efficiency and good stability. AHPP/OVA, CS-AHPP/OVA PEI-AHPP/OVA, and εPL-AHPP/OVA formulations significantly enhanced lymphocyte proliferation and improved the ratio of CD4+/CD8+ T cells. In addition, AHPP/OVA, PEI-AHPP/OVA and εPL-AHPP/OVA formulations induced secretion of cytokines (TNF-α, IFN-γ, IL-4, and IL-6), antibodies (IgG) and antibody subtypes (IgG1 and IgG2a) in immunized mice. These results demonstrate that these formulations generated a strong Th1-biased immune response. Among them, PEI-AHPP/OVA induced the strongest Th1-biased immune response.>Conclusion: In conclusion, PEI-AHPP/OVA nanoparticles may be a potential antigen delivery system for the induction of strong immune responses.
机译:>背景:聚乳酸-乙醇酸(PLGA)纳米颗粒和表面改性的PLGA纳米颗粒由于其控释特性和生物相容性而被广泛研究为抗原或药物载体。但是,大多数PLGA纳米颗粒的抗原负载效率和佐剂活性较低。>目的:本研究的目的是提高PLGA纳米颗粒的抗原负载效率和佐剂活性。>材料和方法:表面阳离子聚合物改性可以通过表面吸附提高PLGA纳米颗粒的抗原负载效率。因此,在这项研究中,制备了壳聚糖改性的PLGA纳米颗粒(CS-AHPP / OVA),聚乙烯亚胺改性的PLGA纳米颗粒(PEI-AHPP / OVA)和ε-聚-L-赖氨酸改性的PLGA纳米颗粒(εPL-AHPP/ OVA)作为抗原传递载体来研究这些纳米颗粒的表征和稳定性。评估了这些纳米粒子在改性前后的佐剂功效。>结果:表面阳离子聚合物改性后,AHP和OVA负载的PLGA纳米粒子(AHPP / OVA)带正电,并且其结构保持完整性。通过表面阳离子聚合物的改性提高了它们的抗原负载能力和纳米颗粒的稳定性。增加的正表面电荷导致更大的OVA吸附容量。在AHPP / OVA和由改性PLGA纳米粒子合成的三种表面阳离子聚合物中,PEI-AHPP / OVA表现出最高的抗原负载效率和良好的稳定性。 AHPP / OVA,CS-AHPP / OVA PEI-AHPP / OVA和εPL-AHPP/ OVA制剂可显着增强淋巴细胞增殖并改善CD4 + / CD8 + T细胞的比例。此外,AHPP / OVA,PEI-AHPP / OVA和εPL-AHPP/ OVA制剂可诱导细胞因子(TNF-α,IFN-γ,IL-4和IL-6),抗体(IgG)和抗体亚型的分泌(免疫小鼠中的IgG1和IgG2a)。这些结果证明这些制剂产生了强烈的Th1偏向的免疫应答。其中,PEI-AHPP / OVA诱导最强的Th1偏向免疫反应。>结论:总之,PEI-AHPP / OVA纳米颗粒可能是诱导强免疫反应的潜在抗原递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号